Transcode Therapeutics News

Transcode Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 15 05:36

Transcode Therapeutics | DEFA14A: Others

Nov 14 05:40

Transcode Therapeutics | DEFA14A: Others

Nov 7 05:10

Transcode Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-3i, LP(0%),3i Management LLC(0%), etc.

Nov 7 05:08

Transcode Therapeutics | 8-K: Current report

Nov 7 05:03

Transcode Therapeutics | DEF 14A: Definitive information statements

Oct 29 04:05

Transcode Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 16 05:25

Transcode Therapeutics | 8-K: Current report

Sep 28 04:05

Transcode Therapeutics | 8-K: Current report

Aug 28 18:09

Transcode Therapeutics | 8-K: Current report

Aug 17 05:08

Transcode Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 15 04:51

Transcode Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-3i, LP(9.9%),3i Management LLC(9.9%), etc.

Jul 27 04:09

Transcode Therapeutics | 8-K: Current report

Jul 24 21:04

Transcode Therapeutics | 424B5: Prospectus

Jul 24 20:19

Transcode Therapeutics | 424B5: Prospectus

Jul 23 04:13

Transcode Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Thomas A. Fitzgerald(5.5%)

Jun 22 04:09

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fitzgerald Thomas A

Jun 19 04:22

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Manting Erik

Jun 19 04:22

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

Jun 19 04:21

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Calais Philippe

Jun 19 04:20